ClinicalTrials.gg
CompletedNCT07883343Updated Oct 20, 2026

Effects of Adding a Registered Dietitian to Rural Community Healthy Behavior Support Services for Management of Type 2 Diabetes

An interventional study of Medical Nutrition Therapy Intervention in Type 2 Diabetes, sponsored by Indiana University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Indiana University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 3 years 4 months after the study started (first participant enrolled May 2023, registered Oct 2026).
Updated Oct 20, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Rural communities experience health care shortages of diabetes services provided by a registered dietitian nutritionist (RDN). This pilot study tested the feasibility of using rural community health screenings to recruit adults with Type 2 Diabetes (T2D) and provide Medical Nutrition Therapy (MNT), testing its impact on health, diet, and physical activity. Recruitment, retention, and adherence rates measured feasibility. Health markers (BMI, non-fasted blood glucose and lipids) were collected at an initial and follow up (6-9 months) screening. Diet (24-hr) and physical activity (7-day) recalls were collected at the MNT visits (initial, 1 mo, 3 mo). Paired t-tests and linear mixed models assessed mean differences between timepoints. Based upon the results from this pilot study, future testing of the efficacy of this approach in a randomized controlled study may be warranted and may allow for expansion of diabetes services in rural Indiana.

Read the detailed description

Summary abstract: Rural communities experience health care shortages of diabetes services provided by a registered dietitian nutritionist (RDN). This pilot study tested the feasibility of using rural community health screenings to recruit adults with Type 2 Diabetes (T2D) and provide Medical Nutrition Therapy (MNT), testing its impact on health, diet, and physical activity. Recruitment, retention, and adherence rates measured feasibility. Health markers [body mass index (BMI), non-fasted blood glucose and lipids, blood pressure, waist circumference] were collected at an initial and follow up (6-9 months) screening. Diet (24-hr) and physical activity (7-day) recalls were collected at the MNT visits (initial, 1 month, 3 month). Paired t-tests and linear mixed models assessed mean differences between timepoints.

Introduction: In the U.S., approximately 38.1 million adults aged 18 years or older have diabetes which is a prevalence rate of 14.7% based on 2021 estimates. Of these cases, 90% to 95% are type 2 diabetes (T2D). The estimated prevalence of diabetes in Indiana is 12.1% based on 2021 estimates.

Individuals with T2D are highly susceptible to major complications such as heart disease, stroke, renal failure, blindness, and amputations. The total estimated cost attributable to diabetes and its complications in the U.S. in 2022 is $412.9 billion. There are significant geographic disparities in diabetes prevalence between rural and urban areas. Prevalence of diabetes has been reported from 9% to 17% higher in rural areas than in urban areas. Diabetes has been identified as one of the top 10 Healthy People 2030 priorities for the rural United States. Rural communities experience health care shortages of not only primary care doctors for diabetes but also services provided by a registered dietitian nutritionist (RDN) such as medical nutrition therapy (MNT) and diabetes education. While RDs have been incorporated in team-based care in primary care clinics, team-based care models and support services (including a RDN) in rural communities are not typically present. This pilot study focused on Indiana rural communities experiencing health care shortages of diabetes service. The study's objectives were to test: (1) the feasibility of using rural community health screening events to recruit participants with T2D, (2) the feasibility of implementing MNT virtually by a RDN for 3 months, (3) the impact of the MNT on health markers of diabetes management, dietary intake and physical activity.

Methods:

Study population: Participants in SIHHH with T2D living in Southern Indiana counties (Crawford, Daviess, Dubois, Greene, Jackson, Lawrence, Martin, Orange, and Washington) were referred by nurses (RN) to the RDN as part of healthy behavior support services. The goal was to recruit 20 adults ≥ 18 years old with body mass index (BMI) ≥ 25 kg/m2 and a T2D diagnosis.

The enrollment of 20 participants was meant to allow the researchers to pilot test the feasibility of MNT delivered virtually by a RDN for 3 months, by assessing metrics regarding recruitment, enrollment and retention as well as the impact on changes in BMI and hemoglobin A1c (HbA1c) from the initial health screening to the follow up health screening. This data was intended to evaluate delivery of the intervention, as well as to obtain data on changes in biometrics for power calculations for a future randomized controlled trial.

Outcome measures: Feasibility outcomes included the number of health events and health screens, recruitment, retention, and adherence to MNT. Behavior outcomes included dietary intake and physical activity. Health outcomes included BMI, HbA1c, non-fasting blood glucose and lipids (total, HDL, and LDL cholesterol, triglycerides), blood pressure, and waist circumference.

Intervention: The SIHHH program provided RN led health screenings at public health centers/clinics, within health ministry centers/offices, mobile units, and health fairs. Health screenings included collection of demographics, weight, height, blood glucose, blood lipids, blood pressure, and waist circumference. HbA1c was calculated using blood glucose [Average HbA1c = (46.7 + non fasting glucose)/28.7]. RNs identified participants who met eligibility criteria of the pilot study and provided information about the MNT service. Individuals who expressed interest signed a consent form to receive the MNT, agreed to researchers' access to their electronic records as part of SIHHH, and agreed to provide information on their diet and physical activity habits. Participants were provided a packet of resources including Healthy Eating and Being Active from the Association of Diabetes Care \& Education Specialists, Meal Planning and Carb Counting from Novo Care of Novo Nordisk, and Healthy and Balanced Eating with MyPlate from United States Department of Agriculture. Participants were also provided a set of food measuring utensils and a My Plate food plate to assist with portion size. As part of the SIHHH Program, follow up health screenings occurred at 6-8 months post the initial screening. This data was evaluated to understand if there is any sustained impact of the MNT.

The MNT intervention was delivered virtually for three months by the RDN, who was also a Certified Diabetes Educator (CDE). During the initial MNT visit, the RDN used motivational interviewing techniques to identify the participant's interests and motivation for diabetes management. Participants set one goal on nutrition/healthy eating and one goal on physical activity. Based on the goals, the RDN provided diabetes education on blood glucose targets, use of blood glucose monitor, menu planning, or carbohydrate counting; eventually all of these topics were included in the subsequent MNT visits. To obtain data on dietary intake and physical activity, respectively, the RDN administered a 24-hr dietary recall and a 7-day physical activity recall (International Physical Activity). The 24-hour dietary recall included details about food/beverage intake, food preparation, and meal timing. The 7-day physical activity recall included details on types and intensity of activities as hours per day and number of days with at least 10 minutes of the activity. The RDN also administered these recalls during the 1- and 3-month visits encouraging health behavior changes to improve blood glucose levels. The RDN continued to address meal planning, carbohydrate counting, portion size, macronutrients, eating out, and physical activity during the 1- and 3-month visits. The RDN continued to use motivational interviewing techniques to assess progress and determine areas for improvement. The MNT intervention ended after the 3-month visit. Repeated measures of the biometric data were collected at the health screening which occurred at 6-8 months post the initial screening.

Data Analysis: Feasibility outcomes including the number of health events and screenings, recruitment, and retention were recorded. Adherence to the intervention was measured by recording attendance at the MNT visits. Dietary intake and physical activity data collected at the initial, 1- and 3-month MNT visits were analyzed using linear mixed models to evaluate changes overtime. The dietary data was assessed using the Nutrition Data System for Research (NDSR, University of Minnesota) for calories, macronutrients and micronutrients and change from initial visit to the 1- and 3- month MNT visits were analyzed. Change from initial visit to the 1- and 3-month MNT visits for hours per day and days of at least 10 minutes of physical activity were analyzed. Health outcomes including BMI, HbA1c, blood glucose, lipids, and blood pressure obtained from the SIHHH initial health screening (prior to MNT) and at the SIHHH follow up health screening (6-8 months) were used to determine changes overtime. Statistical differences from the initial screening to the follow up screening were determined using paired t-tests.

02

Conditions studied

  • Type 2 Diabetes

Keywords

  • Medical Nutrition Therapy
  • Telehealth
  • Type 2 Diabetes
03

In context

Diabetes Mellitus, Type 2

9,589 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,332 are open to participants now.

This study's enrollment of 14 is below the median of 81 across 7,713 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Indiana University is the lead sponsor of 982 studies on the registry; 199 are open to participants now.

Of its 148 completed or terminated interventional studies of FDA-regulated products, 117 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years old
  • Body mass index (BMI) ≥ 25 kg/m2
  • Type 2 diabetes diagnosis

Exclusion criteria

Exclusion Criteria:

  • Type 1 diabetes
  • Gestational diabetes mellitus
  • Currently receiving medical nutrition therapy from a registered dietitian nutritionist
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    Medical Nutrition Therapy Intervention

    In this single arm pilot study, telehealth delivered medical nutrition therapy (MNT) was provided by a registered dietitian nutritionist (RDN) to participants who had type 2 diabetes (T2D).

    Behavioral: Medical Nutrition Therapy Intervention

Interventions

  • BehavioralMedical Nutrition Therapy Intervention

    In this single arm pilot study, telehealth delivered medical nutrition therapy (MNT) was provided by a registered dietitian nutritionist (RDN) to individuals with type 2 diabetes (T2D).

06

What researchers measure

Primary outcomes

  1. Feasibility outcome: Community health events

    The number of community health events that occurred.

    Time frame: From enrollment to end of study data collection at 8 months.

  2. Feasibility outcome: Health screenings at community health events

    The number of individual health screenings that were conducted at the community health events.

    Time frame: From enrollment to end of study data collection at 8 months.

  3. Feasibility outcome: Recruitment Rate

    The percent of individuals identified with type 2 diabetes from the health screenings that were recruited to receive MNT.

    Time frame: From enrollment to 6 months.

  4. Feasibility outcome: Retention rate

    The number of individuals who completed the MNT interventions and follow up health screen.

    Time frame: From enrollment to end of study data collection at 8 months.

  5. Feasibility outcome: Adherence rate

    The participant rate of adherence to MNT.

    Time frame: From enrollment to end of MNT provision at 3 months.

Secondary outcomes

  1. Behavior outcome: Dietary intake

    Dietary intake was collected using a 24 hour recall.

    Time frame: From enrollment to end of MNT at 3 months.

  2. Behavior outcome: Physical Activity

    Physical activity was collected using a 7-day record.

    Time frame: From enrollment to end of MNT at 3 months.

  3. Health outcome: Height

    Height was self reported in inches.

    Time frame: From enrollment to end of study data collection at 8 months.

  4. Health outcome: Weight

    Body weight (lbs) was measured using digital scale.

    Time frame: From enrollment to end of study data collection at 8 months.

  5. Health outcome: Blood glucose

    Non fasting blood glucose (mg/dL) was measured by point of care instrument.

    Time frame: From enrollment to end of study data collection at 8 months.

  6. Health outcome: HbA1c

    HbA1c (%) was calculated using non-fasting blood glucose.

    Time frame: From enrollment to end of study data collection at 8 months.

  7. Health outcome: Blood lipids

    Non fasting total, HDL, LDL cholesterol, triglycerides were measured by point of care instrument (mg/dL).

    Time frame: From enrollment to end of study data collection at 8 months.

  8. Health outcome: Blood pressure

    Blood pressure was measured by digital sphygmomanometer.

    Time frame: From enrollment to end of study data collection at 8 months.

  9. Health outcome: Waist circumference

    Waist circumference (in) was assessed with tape measure.

    Time frame: From enrollment to end of study data collection at 8 months.

  10. Health outcome: BMI

    BMI was calculated from height and weight.

    Time frame: From enrollment to end of study data collection at 8 months.

07

Study locations

1 site
  • Indiana University
    Bloomington, Indiana 47405, United States
08

References and documents

Individual participant data

Plan to share: No — IPD does not need to be shared with other researchers.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2023 to primary completion in Jun 2024, 13 months.

Of 1,924 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's 13 months is below that.

Counting every sponsor, half of 2,101 studies reached it within 20 months; a quarter within 10 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 8, 2026
First posted
Oct 20, 2026
StartActual
May 16, 2023
Primary completionActual
Jun 27, 2024
CompletionActual
Jun 27, 2024
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07883343
Lead sponsor
Indiana University
Responsible party
Lisa Spence (Assistant Professor, Indiana University) — Principal investigator
First posted
Oct 20, 2026
Start date
May 16, 2023
Primary completion
Jun 27, 2024
Completion
Jun 27, 2024
Last update
Oct 20, 2026

Study contacts

Lisa A Spence, PhD, RD
principal investigator · Indiana University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion